Systemic cyclosporin A in high risk penetrating keratoplasties: A case-control study

British Journal of Ophthalmology

Volumn 85, Issue 12, 2001, Pages 1464-1469

  Poon, A C ^a,b   Forbes, J E ^b   Dart, J K G ^b   Subramaniam, S ^b   Bunce, C ^b   Madison, P ^b   Ficker, L A ^b   Tuft, S J ^b   Gartry, D S ^b   Buckley, R J ^b  

^a Moorfields Eye Hospital ^*  (Australia)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CORNEA DISEASE; CORNEA PERFORATION; DRUG EFFECT; FEMALE; GRAFT FAILURE; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; TREATMENT INDICATION;

ADULT; AGED; CASE-CONTROL STUDIES; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; VISUAL ACUITY;

EID: 0035679066     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.85.12.1464     Document Type: Article

References (19)

1. Systemic cyclosporine in high-risk keratoplasty: Long term results
2. Systemic cyclosporine in high-risk keratoplasuty: Short versus long-term therapy
3. Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients: A retrospective study
4. Traitement par ciclosporine A, a doses faibles, dans les keratoplasties transfixiantes a haut risquei. Etude bicentrique de 90 cas
5. The effect of cyclosporin A on corneal graft survival
6. Topical cyclosporine in high-risk corneal transplants
7. Topical cyclosporine A to prevent the corneal rejection
8. Local treatment of corneal transplant in humans with cyclosporin A
9. Topical cyclosporin A in the treatment of anterior segment inflammatory disease
10. The high-risk keratoplasty patient - Quo vadis?
11. Management of inflammation in the cornea and conjunctiva
12. Influence of advanced recipient and donor age on the outcome of corneal transplantation
13. Prospective, randomized clinical evaluation of optisol vs organ culture corneal storage media
14. Optisol corneal storage medium
15. Endothelial cell survival on transplanted human corneas preserved by organ culture with 1.35% chondroitin sulfate
16. Clinical comparison of grafts stored in McCarey-Kaufman medium at 4°C and in corneal organ culture at 31°C
17. Reducing systemic complications in cyclosporin treatment for high risk keratoplasty
18. Incidence and consequences of post-transplantation lymphoproliferative disorders
19. Cyclosporine induces cancer progression by a cell-autonomous mechanism